Early-onset duodenal perforation during bevacizumab-containing chemotherapy in a patient with ovarian cancer: a case report
{{output}}
Background: Bevacizumab-induced gastrointestinal perforation is a potentially fatal adverse event. However, duodenal perforations are rare. Conversely, patients with cancer often have concomitant rheumatoid arthritis and may be t... ...
